Sofosbuvir plus peginterferon/ribavirin demonstrates virologic response rates in G3 hep C patients
Results presented today at The International Liver Congress 2015 demonstrate that hepatitis C (HCV)-infected genotype-3 (GT-3) patients, with and without cirrhosis, receiving 24 weeks of sofosbuvir (SOF) in combination with ...
Apr 25, 2015
0
4